Literature DB >> 12670371

Associations among nucleated cell, CD34+ cell and colony-forming cell contents in cord blood units obtained through a standardized banking process.

P Aroviita1, K Teramo, P Westman, V Hiilesmaa, R Kekomäki.   

Abstract

BACKGROUND AND OBJECTIVES: Nucleated cell content is one of the main components used when evaluating cord blood (CB) units for clinical use. However, other indicators of the haematopoietic potential of a CB unit, such as CD34+ cell and colony-forming cell (CFU-TOT) content, have also been investigated. The aim of this study was to determine whether the CD34+ cell content could be used in selecting CB collections for banking.
MATERIALS AND METHODS: The collection data, as well as cellular contents of 588 CB collections obtained using a standardized CB banking process, were analysed.
RESULTS: Altogether, 526 CB units from the 588 collections accepted for processing were included in international search registries. The volume collected was, as expected, 69 ml (range 28-116 ml). The correlation between total CD34+ cell and CFU-TOT (n = 88) content in the CB collection was higher (r = 0.87) than the correlation between the total nucleated cell and CFU-TOT content (r = 0.69, both P < 0.0001). The correlations of pre- and postvolume reduction values of the total nucleated cell and CD34+ cell numbers were highly significant (r = 0.96, P < 0.0001, both). The total CFU-TOT content of the CB collection correlated significantly with the total CD34+ cell content of the CB unit before cryopreservation (but after volume reduction) (r = 0.89, P < 0.0001).
CONCLUSIONS: CD34+ cell content predicts the haematopoietic potential of a CB unit better than nucleated cell content. Accordingly, the CD34+ cell content of CB could be used to select CB for banking purposes and for transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670371     DOI: 10.1046/j.1423-0410.2003.00276.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  8 in total

Review 1.  Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective.

Authors:  Ivan N Rich
Journal:  Stem Cells Transl Med       Date:  2015-07-09       Impact factor: 6.940

Review 2.  Ex-vivo expansion of red blood cells: how real for transfusion in humans?

Authors:  Anna Rita Migliaccio; Elena Masselli; Lilian Varricchio; Carolyn Whitsett
Journal:  Blood Rev       Date:  2011-12-15       Impact factor: 8.250

3.  Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.

Authors:  Ariana Jacome; Susana Navarro; Paula Río; Rosa M Yañez; Africa González-Murillo; M Luz Lozano; Maria Luisa Lamana; Julian Sevilla; Teresa Olive; Cristina Diaz-Heredia; Isabel Badell; Jesus Estella; Luis Madero; Guillermo Guenechea; José Casado; Jose C Segovia; Juan A Bueren
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

4.  Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells.

Authors:  Tuija Kekarainen; Sirkka Mannelin; Jarmo Laine; Taina Jaatinen
Journal:  BMC Cell Biol       Date:  2006-08-01       Impact factor: 4.241

5.  Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units.

Authors:  John Patterson; Cally H Moore; Emily Palser; Jason C Hearn; Daniela Dumitru; Holli A Harper; Ivan N Rich
Journal:  J Transl Med       Date:  2015-03-18       Impact factor: 5.531

Review 6.  Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.

Authors:  Olivier Hequet
Journal:  J Blood Med       Date:  2015-02-18

7.  Optimizing cord blood collections: Assessing the role of maternal and neonatal factors.

Authors:  Joseph Philip; Neerja Kushwaha; Tathagata Chatterjee; Rajiv Singh Mallhi
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

Review 8.  Umbilical cord blood quality and quantity: Collection up to transplantation.

Authors:  Seyed Hadi Mousavi; Morteza Zarrabi; Saeid Abroun; Mona Ahmadipanah; Bahareh Abbaspanah
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.